Discontinued — last reported Q3 '25
Quest Diagnostics Non-Controlling Interests increased by 733.3% to $300.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 809.1%, from $33.00M to $300.00M. Over 5 years (FY 2020 to FY 2025), Non-Controlling Interests shows a downward trend with a -6.4% CAGR.
An increase suggests the company has expanded its consolidated operations through partially-owned subsidiaries, while a decrease may indicate buyouts of minority stakes.
This represents the portion of equity in a subsidiary not attributable, directly or indirectly, to the parent company. I...
Common in large conglomerates or companies with complex joint venture structures; peers often report this as a small fraction of total equity.
noncontrolling_interests| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $41.00M | $40.00M | $39.00M | $38.00M | $39.00M | $37.00M | $37.00M | $38.00M | $38.00M | $38.00M | $35.00M | $37.00M | $39.00M | $32.00M | $35.00M | $33.00M | $37.00M | $37.00M | $36.00M | $300.00M |
| QoQ Change | — | -2.4% | -2.5% | -2.6% | +2.6% | -5.1% | +0.0% | +2.7% | +0.0% | +0.0% | -7.9% | +5.7% | +5.4% | -17.9% | +9.4% | -5.7% | +12.1% | +0.0% | -2.7% | +733.3% |
| YoY Change | — | — | — | — | -4.9% | -7.5% | -5.1% | +0.0% | -2.6% | +2.7% | -5.4% | -2.6% | +2.6% | -15.8% | +0.0% | -10.8% | -5.1% | +15.6% | +2.9% | +809.1% |